Skip to content

Generate Biomedicines, Inc.

GENB Nasdaq SEC CIK 2100782

Follow Generate Biomedicines Weekly email: filings, results, news

News

2 stories filed under Generate Biomedicines

Generate Biomedicines stock price target raised to $30 by H.C. Wainwright on asthma data

Markets 27 d ago

Generate Biomedicines stock jumps as post-IPO lock-up set to expire

Deals 30 d ago

Profile

Headquarters: SOMERVILLE, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator